<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-Q727791E</identifier><date>2019</date><creator>Koprivnikar Krajnc, Miha</creator><creator>Lah Turnšek, Tamara</creator><creator>Novak, Metka</creator><creator>Pestell, Richard G.</creator><relation>documents/doc/Q/URN_NBN_SI_doc-Q727791E_001.pdf</relation><relation>documents/doc/Q/URN_NBN_SI_doc-Q727791E_001.txt</relation><format format_type="issue">4</format><format format_type="volume">53</format><format format_type="type">article</format><format format_type="extent">str. 397-406, II</format><identifier identifier_type="DOI">10.2478/raon-2019-0057</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">5234511</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-Q727791E</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">citokini</subject><subject language_type_id="slv">glioblastom</subject><subject language_type_id="slv">napoved preživetja</subject><subject language_type_id="slv">rak (medicina)</subject><title>Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme</title></Record>